Highlights of Our NGS Program
A complete spectrum of testing options - The most comprehensive combination of tests spanning from single-gene, disease-specific and broad reach tumor profiles in tissue and plasma specimens, in addition to bone marrow and peripheral blood samples.
Full-range molecular diagnostic technologies – NGS is a molecular methodology that is part of a broader family of molecular tests. In addition to NGS, NeoGenomics provides a wide array of quantitative PCR, Sanger sequencing, and send-out SNP microarray services.
Heme Targeted Profiles - Actionable disease - specific profiles, such as NeoTYPE® MDS/CMML Profile that informs diagnosis, prognosis and predictive information.
RNA-Based Fusion Panels for Solid Tumors - Pan-tumor and disease-specific panels to guide therapeutic management, such as NTRK NGS Fusion Panel to detect NTRK1/2/3 for TRK inhibitor therapy eligibility.
NeoGenomics prides itself on our unparalleled customer support team. If you have questions regarding test information, specimen requirements, turnaround times, test add-on, and patient results please feel free to reach out to a Client Services Advocate at firstname.lastname@example.org.
View our full menu of available NGS tests with printable descriptions and specimen requirements.
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients